Observational studyThe Korean journal of internal medicine2019

Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study.

Seng Chan You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.